Stéphane Bancel
CEO & DirectorMr. Stéphane Bancel, M.B.A., is Director at Commonwealth Fusion Systems LLC since January 2026. He served as a Board Director at Indigo Agriculture Inc since 2020 until July 2025. Mr Bancel served as an Interim President at Valera LLC. He serves as a CEO and Director at Valera LLC. Mr. Bancel serves as a Special Partner at Flagship Pioneering, Inc since February 2021. Mr. Bancel served as Venture Partner of Flagship Pioneering till February 2021 and a Trustee of the Museum of Science. He joined Flagship Pioneering Inc as a Senior Partner since joining on May 22, 2013. Mr. Bancel serves as the Founding Chief Executive Officer of Moderna, Inc. since October 2011. He served as a Senior Advisor of Institut Mérieux SA. He served as the Chief Executive Officer of bioMérieux SA at bioMérieux, Inc. until July 20, 2011. He accelerated the sales growth rate, enhanced its position as a global leader in clinical microbiology and re-accelerated its immunoassay franchise by focusing on high medical value biomarkers. Mr. Bancel served as an Executive Chairman at BG Medicine, Inc from July 2011 to November 1, 2013. From July 2000 to March 2006, Mr. Bancel worked in the United States, Great Britain and Belgium for Eli Lilly laboratories, where he successively served as Managing Director, Executive Director for Global Manufacturing Strategy, Global Supply Chain and U.S. Distribution and Supply Chain Manager. He served as President of Moderna, Inc. From 1995 to 1998, he worked at bioMérieux, where he was In Charge of the industrial microbiology business for the Asia-Pacific region Sales and served as Marketing Director. He had been a Supervisory Director of Qiagen N.V. since June 26, 2013. He serves as an Independent Director of Generate Biomedicines, Inc. and served as its Director since September 2019. He serves as a Director of Moderna, Inc. since March 2011 and Tafkak, Inc. Mr. Bancel served as the Chairman of BG Medicine, Inc. since November 1, 2013. He served as the Chairman of bioTheranostics, Inc. He served as a Director of Syros Pharmaceuticals, Inc. since November 21, 2013 until June 08, 2017. He served as a Director of Targanta Therapeutics Corp., from August 2008 to February 25, 2009. He served as Director of BG Medicine, Inc. since January 2010. He served as a Director of Indigo Ag, Inc since August 2020 until 2025. He served as Director of BG Medicine, Inc. from January 2010 to May 12, 2015. He was elected a 2009 Young Global Leader by the World Economic Forum. He was elected best Chief Executive Officer for Investor Relations in France in 2009 and was ranked 1 Chief Executive Officer in the Biotechnology sector according to the 2011 Thomson Reuters Pan European EXTEL Study. Mr. Bancel holds a Master of Engineering degree from École Centrale Paris (ECP), a Master of Science in Chemical Engineering from the University of Minnesota and an M.B.A. from Harvard Business School.
Positions
- Company NameModerna, Inc.Stock CodeMRNAPositionCEO & DirectorColleagues
- NBNoubar B. AfeyanCo-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board
- SHStephen HogePresident
- JMJames M. MockChief Financial Officer
- STShannon Thyme KlingerChief Legal Officer & Corporate Secretary
- JAJuan AndresChief Operating Officer
- DEDarin EdwardsExecutive Director
- JWJack W. SzostakChairman of Scientific Advisory Board
- FNFrancois NaderIndependent Non Executive Director
